{"id":"W4306941118","doi":"10.1038/s41375-022-01724-9","title":"Finding consistency in classifications of myeloid neoplasms: a perspective on behalf of the International Workshop for Myelodysplastic Syndromes","year":2022,"lang":"en","type":"letter","venue":"Leukemia","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":28,"is_retracted":false,"has_abstract":false,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre","funders":"Takeda Oncology; Genentech; National Institutes of Health; Astellas Pharma; Pfizer; Incyte; CTI Biopharma; bluebird bio; Agios Pharmaceuticals; Syndax Pharmaceuticals; National Heart, Lung, and Blood Institute; Edward P. Evans Foundation; Acceleron; Astex Pharmaceuticals; Daiichi-Sankyo; MacroGenics; Celldex Therapeutics; Jazz Pharmaceuticals; Leukemia and Lymphoma Society; Apellis Pharmaceuticals; Alexion Pharmaceuticals; Daiichi Sankyo Europe; Servier; Aplastic Anemia and MDS International Foundation; Gilead Sciences; BioCryst; Celgene; Bristol-Myers Squibb; AstraZeneca; Cardinal Health; Amgen; American Cancer Society","keywords":"Myelodysplastic syndromes; Consistency (knowledge bases); Medicine; Myeloid; Perspective (graphical); Oncology; Myeloid leukemia; Internal medicine; Immunology; Computer science; Bone marrow; Artificial intelligence","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.1026433,0.000821362,0.003310009,0.004426531,0.009706831,0.01534412,0.009738206,0.05537215,0.004409496],"category_scores_gemma":[0.3212886,0.001552233,0.002135709,0.003991283,0.01635615,0.01740665,0.00868808,0.0724822,0.00219654],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.01287371,"about_ca_system_score_gemma":0.01583741,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.01203563,"about_ca_topic_score_gemma":0.01941078,"domain_scores_codex":[0.9145483,0.03820222,0.01749184,0.00750758,0.01846986,0.003780164],"domain_scores_gemma":[0.5836382,0.2933337,0.01338448,0.01207475,0.07673912,0.02082975],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0001090208,0.00008838429,0.00997477,0.0002966507,0.00009572126,0.00276609,0.002737587,0.0002201479,0.0004761004,0.01639659,0.9058509,0.06098807],"study_design_scores_gemma":[0.0002379719,0.0001348817,0.008422211,0.003868345,0.0001925164,0.007403729,0.01208852,0.002121066,0.0005979473,0.1380118,0.8265939,0.0003270635],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","genre_codex":"commentary","genre_gemma":"commentary","genre_scores_codex":[0.0002739941,0.0007644453,0.000301899,0.9943714,0.003695182,0.000009380581,0.00002543951,0.000009312126,0.0005489554],"genre_scores_gemma":[0.0125272,0.002425076,0.005960098,0.9200495,0.05718646,0.0001295388,0.0001249232,0.00007458963,0.001522557],"genre_candidate":"commentary","genre_consensus":"commentary","teacher_disagreement_score":0.1026433,"threshold_uncertainty_score":0.542836,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.0518485078356917,"score_gpt":0.327909335146388,"score_spread":0.2760608273106964,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}